Guangchuan Wang

4.7k total citations · 2 hit papers
82 papers, 2.9k citations indexed

About

Guangchuan Wang is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Guangchuan Wang has authored 82 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 27 papers in Epidemiology and 25 papers in Molecular Biology. Recurrent topics in Guangchuan Wang's work include Liver Disease and Transplantation (26 papers), Liver Disease Diagnosis and Treatment (25 papers) and Organ Transplantation Techniques and Outcomes (18 papers). Guangchuan Wang is often cited by papers focused on Liver Disease and Transplantation (26 papers), Liver Disease Diagnosis and Treatment (25 papers) and Organ Transplantation Techniques and Outcomes (18 papers). Guangchuan Wang collaborates with scholars based in China, United States and Belarus. Guangchuan Wang's co-authors include Ruikang Tang, Sidi Chen, Youssef Errami, Lupeng Ye, Ryan D. Chow, Xiaoyun Dai, Matthew B. Dong, Xurong Xu, Jonathan J. Park and Chunqing Zhang and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Guangchuan Wang

78 papers receiving 2.9k citations

Hit Papers

A genome-scale gain-of-function CRISPR screen in CD8 T ce... 2022 2026 2023 2024 2022 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangchuan Wang China 29 1.3k 666 524 417 411 82 2.9k
Feng Shen China 25 1.2k 0.9× 757 1.1× 333 0.6× 380 0.9× 240 0.6× 94 2.8k
Hongwei Cheng China 35 1.7k 1.2× 426 0.6× 1.3k 2.5× 392 0.9× 217 0.5× 101 4.3k
Yajun Guo China 32 1.6k 1.2× 586 0.9× 373 0.7× 141 0.3× 709 1.7× 99 3.0k
Guoying Zhou China 34 788 0.6× 854 1.3× 265 0.5× 889 2.1× 937 2.3× 84 2.9k
Xuan Wang China 29 2.4k 1.8× 792 1.2× 471 0.9× 417 1.0× 346 0.8× 120 4.0k
Ting Liu China 31 1.4k 1.0× 435 0.7× 1.1k 2.1× 363 0.9× 717 1.7× 132 3.6k
Guanxin Shen China 29 860 0.6× 451 0.7× 425 0.8× 321 0.8× 1.1k 2.7× 91 2.6k
Yasuo Yoshioka Japan 35 1.3k 1.0× 657 1.0× 407 0.8× 533 1.3× 666 1.6× 219 4.2k
Zhe Wang China 32 1.5k 1.1× 890 1.3× 357 0.7× 290 0.7× 686 1.7× 165 3.6k
Ling Ye China 30 2.1k 1.5× 942 1.4× 299 0.6× 544 1.3× 921 2.2× 133 5.6k

Countries citing papers authored by Guangchuan Wang

Since Specialization
Citations

This map shows the geographic impact of Guangchuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangchuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangchuan Wang more than expected).

Fields of papers citing papers by Guangchuan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangchuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangchuan Wang. The network helps show where Guangchuan Wang may publish in the future.

Co-authorship network of co-authors of Guangchuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangchuan Wang. A scholar is included among the top collaborators of Guangchuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangchuan Wang. Guangchuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Guangmin, Zijian Qiao, Huimin Wang, et al.. (2025). Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses. Biomedicine & Pharmacotherapy. 188. 118180–118180.
2.
Li, Shuojun, Mingzhu Yin, Tiange Yang, et al.. (2025). Amplifying antigen-induced cellular responses with proximity labelling. Nature. 647(8089). 506–516. 1 indexed citations
3.
Wang, Qi, Guangchuan Wang, Jingjing Li, et al.. (2024). Characterizing Vericiguat Treatment in Heart Failure: A Multicenter Real-World Study in China. Reviews in Cardiovascular Medicine. 25(12). 427–427.
4.
Tie, Jun, Guangchuan Wang, Zhengjie Li, et al.. (2024). Efficacy of TIPS plus extrahepatic collateral embolisation in real-world data: a validation study. BMJ Open Gastroenterology. 11(1). e001310–e001310. 2 indexed citations
5.
Chang, Ming‐Hui, et al.. (2024). GTPBP8 mitigates nonalcoholic steatohepatitis (NASH) by depressing hepatic oxidative stress and mitochondrial dysfunction via PGC-1α signaling. Free Radical Biology and Medicine. 229. 312–332. 3 indexed citations
6.
Zheng, Qi, Huairui Yuan, Guangchuan Wang, et al.. (2024). Mitochondrial pyruvate carriers control airway basal progenitor cell function through glycolytic-epigenetic reprogramming. Cell stem cell. 32(1). 105–120.e6. 9 indexed citations
7.
Wang, Jinchao, Guangchuan Wang, Wanli Jiang, et al.. (2023). Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation. International Immunopharmacology. 115. 109605–109605. 9 indexed citations
8.
Renauer, Paul, Jonathan J. Park, Meizhu Bai, et al.. (2023). Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function. Cancer Immunology Research. 11(8). 1068–1084. 19 indexed citations
9.
Chen, Jian, Zhaoliang Su, & Guangchuan Wang. (2023). Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control. Signal Transduction and Targeted Therapy. 8(1). 411–411. 3 indexed citations
10.
Zhang, Ming, Wei Wu, Jinjun Chen, et al.. (2023). Hepatic Venous Occlusion Type of Budd–Chiari Syndrome versus Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstructive Syndrome: A Multi-Center Retrospective Study. Journal of Personalized Medicine. 13(4). 603–603. 3 indexed citations
11.
Wang, Guangchuan, Ryan D. Chow, Lvyun Zhu, et al.. (2020). CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade. Cancer Discovery. 10(12). 1912–1933. 87 indexed citations
12.
Wang, Guangchuan, et al.. (2020). Long noncoding RNA LBX2-AS1-modulated miR-4766-5p regulates gastric cancer development through targeting CXCL5. Cancer Cell International. 20(1). 497–497. 9 indexed citations
13.
14.
Ye, Lupeng, Jonathan J. Park, Matthew B. Dong, et al.. (2019). In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma. Nature Biotechnology. 37(11). 1302–1313. 148 indexed citations
15.
Wang, Guangchuan, Ryan D. Chow, Lupeng Ye, et al.. (2018). Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR–mediated direct in vivo screening. Science Advances. 4(2). eaao5508–eaao5508. 72 indexed citations
16.
Chow, Ryan D., Christopher D. Guzman, Guangchuan Wang, et al.. (2017). AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nature Neuroscience. 20(10). 1329–1341. 175 indexed citations
17.
Wang, Guangchuan, Yaling He, Jianfeng Han, et al.. (2014). Crystal Structures of Enterovirus 71 (EV71) Recombinant Virus Particles Provide Insights into Vaccine Design. Journal of Biological Chemistry. 290(6). 3198–3208. 22 indexed citations
18.
Wang, Guangchuan, et al.. (2014). Risk factors for early rebleeding and mortality in acute variceal hemorrhage. World Journal of Gastroenterology. 20(47). 17941–17948. 20 indexed citations
20.
Wang, Guangchuan, Xiaofeng Li, Lijuan Mo, et al.. (2012). Eggshell‐Inspired Biomineralization Generates Vaccines that Do Not Require Refrigeration. Angewandte Chemie International Edition. 51(42). 10576–10579. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026